Chongqing Chemdad Debuts New Technology at CPHI China 2023
Chongqing Chemdad participated in the 21st CPhI China in Shanghai on June 19, 2023. At the exhibition, the company showcased its core technological achievements, including its independently developed high-efficiency API synthesis processes and API delivery technologies.
June 19, 2023, Chongqing Chemdad made its presence felt at the 21st CPHI China at the Shanghai New International Expo Centre. This event, Asia's largest and most international pharmaceutical industry gathering, attracted over 3,000 companies and more than 55,000 professional attendees from over 110 countries and regions worldwide.
Chemdad's booth was strategically located at the core position of E1 Hall, F39-C8, where it showcased two key technological achievements: its independently developed high-efficiency API synthesis process, which optimizes costs and enhances quality, and its API delivery technology, which indirectly improves drug bioavailability. Thanks to these innovative technologies, Chemdad was able to compete on the same stage as global pharmaceutical leaders like Pfizer and Merck, attracting numerous international buyers for discussions. According to the company's head of overseas business, the team hosted clients from more than 20 countries and regions during the exhibition and reached several preliminary cooperation agreements, laying the foundation for future global market expansion.
This exhibition was a significant display of Chemdad's "API technology and international supply capabilities" and a symbol of the company's deepening global strategy. Looking ahead, we will continue to leverage the strong supply chain advantages of China's API industry, deepen long-term partnerships with global pharmaceutical partners, and commit to providing stable, compliant, and cost-effective API solutions to customers worldwide.